Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by bionicjoeon May 18, 2019 3:55pm
63 Views
Post# 29758630

RE:RE:RE:RE:RE:RE:RE:I agree

RE:RE:RE:RE:RE:RE:RE:I agree" I'm glad that you agree that you really wanted a beverage partner but now that you didn't get one you pretend to think it's better not to have one."

There's no pretending about it. The company's present course of action to partner with multiple players in different sectors is the correct one.  As an example if ACB wishes to co-develop products for the cosmetic market then you try to work out a deal with a key player in the cosmetic industry separate from everything else. You can apply that formula for growth to many other industries where in the end you have a vast stable of consumer products covering just about everything imaginable. That would make ACB more valuable. Unlike a 1 trick pony like Canopy which will be dependent on beverages to satisfy its largest and influencial shareholder, if an ACB beverage line doesn't work out hey'll have other partnerships in multiple fields to take up the slack. They won't have all their eggs in one basket like Canopy will with their reliance on pleasing a beer manufacturer.

Right now ACB sees the berverage demand as too small to justify the expense of creating brand awareness for a market that will generate 2% return on investment. If Constellation Brand thinks they can make it work all the power to them but I think Canopy shareholders will be in for a deep disappointment when sales of beverages don't match expectations this fall.
Bullboard Posts